(19)
(11) EP 4 366 625 A2

(12)

(88) Date of publication A3:
16.02.2023

(43) Date of publication:
15.05.2024 Bulletin 2024/20

(21) Application number: 22744692.9

(22) Date of filing: 05.07.2022
(51) International Patent Classification (IPC): 
A61B 17/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61B 17/00234; A61B 17/12013; A61B 2017/00022; A61B 2017/00212; A61B 2017/00221; A61B 2017/00827; A61B 2017/00876; A61F 5/0069; A61F 2005/0016; A61M 39/02; A61N 1/0509; A61N 1/0517; A61N 1/36007; A61N 1/36171; A61N 1/36175; A61N 1/36178; A61N 1/37211; A61N 1/3787; G16H 10/20; G16H 20/30; G16H 40/40; G16H 40/63; G16H 40/67
(86) International application number:
PCT/EP2022/068597
(87) International publication number:
WO 2023/280858 (12.01.2023 Gazette 2023/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 06.07.2021 US 202117367656
30.08.2021 SE 2151027
18.02.2022 SE 2250227

(71) Applicant: Implantica Patent Ltd.
223 70 Lund (SE)

(72) Inventor:
  • FORSELL, Peter
    223 70 Lund (SE)

(74) Representative: AWA Sweden AB 
Box 5117
200 71 Malmö
200 71 Malmö (SE)

   


(54) TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE